scholarly journals A comparison of the safety and efficacy of the VenaBlock cyanoacrylate-based endovenous system versus 1470 nm endovascular biradial laser in the treatment of truncal insufficiency of superficial veins: six-month outcomes of the ESVETIS observational study

2019 ◽  
Vol 27 (1) ◽  
pp. 3-9
Author(s):  
Justyna Wilczko ◽  
Cezary Szary ◽  
Dominika Plucińska ◽  
Tomasz Grzela
Keyword(s):  
Observational Study ◽  
Safety And Efficacy ◽  
System Versus

An Observational Study of the Safety and Efficacy of Tissue Stabilized-Guided Subcision to Improve the Appearance of Cellulite

2017 ◽  
Vol 1 ◽  
pp. s81
Author(s):  
Roy G Geronemus ◽  
Jeremy A Brauer ◽  
Suzanne L Kilmer ◽  
Simeon H Wall, Jr. ◽  
Jeremy B Green ◽  
...  
Keyword(s):  
Observational Study ◽  
Safety And Efficacy

Abstract Not Available

Safety and Efficacy of Calcium Folinate in Psoriasis: An Observational Study

2010 ◽  
Vol 23 (2) ◽  
pp. 649-653 ◽  
Author(s):  
M. Carlesimo ◽  
E. Mari ◽  
A. Arcese ◽  
F. De Angelis ◽  
E. Palese ◽  
...  
Keyword(s):  
Observational Study ◽  
Calcium Folinate ◽  
Safety And Efficacy

scholarly journals Safety and Efficacy of Mobility Interventions in Patients with Femoral Catheters in the ICU: A Prospective Observational Study

2013 ◽  
Vol 24 (2) ◽  
pp. 12-17 ◽  
Author(s):  
Christiane Perme ◽  
Theresa Nalty ◽  
Chris Winkelman ◽  
Ricardo Kenji Nawa ◽  
Faisal Masud
Keyword(s):  
Observational Study ◽  
Prospective Observational Study ◽  
Safety And Efficacy

Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting

2008 ◽  
Vol 99 (01) ◽  
pp. 52-58 ◽  
Author(s):  
Elena Santagostino ◽  
Albert Faradji ◽  
Alfonso Iorio ◽  
Jan van der Meer ◽  
Jørgen Ingerslev ◽  
...  
Keyword(s):  
Observational Study ◽  
Factor Viii ◽  
De Novo ◽  
Observation Time ◽  
Full Length ◽  
Recombinant Factor Viii ◽  
Phase Iii ◽  
Haemophilia A ◽  
Severe Haemophilia ◽  
Safety And Efficacy

SummaryThe safety of full-length sucrose-formulated recombinant factor VIII (rFVIII-FS; KOGENATE® FS) for up to 24 months of use was evaluated in a postmarketing observational study in Europe. Long-term safety and efficacy data were available for 212 patients with severe haemophilia A, including 13 previously untreated patients (PUPs) and 12 patients with 1–19 exposure days (EDs). Patients accumulated a mean (± SD) of 187 (121) EDs to rFVIII-FS and received a total of 39,627 infusions, mainly for prophylaxis and for the treatment of 4,283 spontaneous or trauma-related bleeds during an average observation time of 710 (136) days. Of these bleeding episodes, 85.4% were successfully treated with one or two infusions of rFVIII-FS. Haemostasis was also evaluated during 46 minor to major surgical pro- cedures, and the response to infusion was “excellent” or “good” in all cases. FVIII inhibitor formation was observed in six patients (two de novo; four persistent or recurrent). The de novo cases represent 8.0% (2 of 25) of patients who reported 0–19 previous EDs at study entry. Four of the five patients who reported possible drug-related adverse effects developed inhibitors. The results of this observational study demonstrate the efficacy and safety of rFVIII-FS during normal clinical use in the treatment of patients with severe haemophilia A. Furthermore, these findings are consistent with those of previous phase III clinical studies with rFVIII-FS, particularly with regard to its efficacy and low incidence of inhibitor formation.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece

2018 ◽  
Vol 49 ◽  
pp. 61-66 ◽  
Author(s):  
Argyrios Tzouvelekis ◽  
Theodoros Karampitsakos ◽  
Maria Kontou ◽  
Andreas Granitsas ◽  
Ioanna Malliou ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Observational Study ◽  
Real Life ◽  
Safety And Efficacy

scholarly journals Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study

2021 ◽  
Vol 40 ◽  
pp. 41-46
Author(s):  
Ozgur Sogut ◽  
Mehmet Mustafa Can ◽  
Ramazan Guven ◽  
Onur Kaplan ◽  
Hüseyin Ergenc ◽  
...  
Keyword(s):  
Observational Study ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document